Skip to main content
Erschienen in: Supportive Care in Cancer 9/2011

01.09.2011 | Original Article

Use of unnecessary medications by patients with advanced cancer: cross-sectional survey

verfasst von: Angelo Fede, Michele Miranda, Daniella Antonangelo, Ligia Trevizan, Henrique Schaffhausser, Bruno Hamermesz, Camile Zimmermann, Auro Del Giglio, Rachel P. Riechelmann

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Cancer patients at the end of life take numerous medications. However, it has not been assessed what proportion of patients take unnecessary medications and which patients are at risk for doing so.

Methods

Cross-sectional survey of medications utilized by terminally ill ambulatory cancer patients, with the aim of identifying medications considered unnecessary as per explicit criteria. The criteria took into account whether drugs could benefit patients with terminal cancer.

Results

Among 87 patients, 21 (24%, 95% confidence interval [CI] 15.6–34.5%) were taking at least one unnecessary medication, the most common being gastric protectors. In multivariable analyses, patients with Charlson Comobidity Index ≤ 1 (OR: 4.49, CI95% 1.32–15.26; p = 0.01) or whose medication list had not been reconciled by physicians (OR: 6.38, CI95% 1.21–33.40; p = 0.02) were more likely to use an unnecessary medication.

Conclusion

Patients with advanced cancer take many medications considered unnecessary. Medication reconciliation should be performed routinely for these patients.
Literatur
1.
2.
Zurück zum Zitat Honegger HP (1991) Avoiding futility: assessment of cancer patients in intensive care units. Ann Oncol 2(8):530–531PubMed Honegger HP (1991) Avoiding futility: assessment of cancer patients in intensive care units. Ann Oncol 2(8):530–531PubMed
3.
Zurück zum Zitat von Gruenigen VE, Daly BJ (2005) Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 97(2):638–644CrossRef von Gruenigen VE, Daly BJ (2005) Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 97(2):638–644CrossRef
4.
Zurück zum Zitat Jecker NS, Pearlman RA (1992) Medical futility. Who decides? Arch Intern Med 152(6):1140–1144PubMedCrossRef Jecker NS, Pearlman RA (1992) Medical futility. Who decides? Arch Intern Med 152(6):1140–1144PubMedCrossRef
5.
Zurück zum Zitat Burt RA (2002) The medical futility debate: patient choice, physician obligation, and end-of-life care. J Palliat Med 5(2):249–254PubMedCrossRef Burt RA (2002) The medical futility debate: patient choice, physician obligation, and end-of-life care. J Palliat Med 5(2):249–254PubMedCrossRef
6.
Zurück zum Zitat Cantor MD, Braddock CH 3rd, Derse AR et al (2003) Do-not-resuscitate orders and medical futility. Arch Intern Med 163(22):2689–2694PubMedCrossRef Cantor MD, Braddock CH 3rd, Derse AR et al (2003) Do-not-resuscitate orders and medical futility. Arch Intern Med 163(22):2689–2694PubMedCrossRef
7.
Zurück zum Zitat Kasman DL (2004) When is medical treatment futile? A guide for students, residents, and physicians. J Gen Intern Med 19(10):1053–1056PubMedCrossRef Kasman DL (2004) When is medical treatment futile? A guide for students, residents, and physicians. J Gen Intern Med 19(10):1053–1056PubMedCrossRef
8.
Zurück zum Zitat Khatcheressian J, Harrington SB, Lyckholm LJ, Smith TJ (2008) 'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) 22(8):881–888, discussion 893, 896, 898 Khatcheressian J, Harrington SB, Lyckholm LJ, Smith TJ (2008) 'Futile care': what to do when your patient insists on chemotherapy that likely won't help. Oncology (Williston Park) 22(8):881–888, discussion 893, 896, 898
9.
Zurück zum Zitat Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17(6):745–748PubMedCrossRef Riechelmann RP, Krzyzanowska MK, Zimmermann C (2009) Futile medication use in terminally ill cancer patients. Support Care Cancer 17(6):745–748PubMedCrossRef
10.
Zurück zum Zitat Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412PubMedCrossRef Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412PubMedCrossRef
11.
Zurück zum Zitat Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595PubMedCrossRef Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM (2007) Prescribing in palliative care as death approaches. J Am Geriatr Soc 55(4):590–595PubMedCrossRef
12.
Zurück zum Zitat Riechelmann RP, Zimmermann C, Chin SN et al (2008) Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 35(5):535–543PubMedCrossRef Riechelmann RP, Zimmermann C, Chin SN et al (2008) Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 35(5):535–543PubMedCrossRef
13.
Zurück zum Zitat Corcoran ME (1997) Polypharmacy in the older patient with cancer. Cancer Control 4(5):419–428PubMed Corcoran ME (1997) Polypharmacy in the older patient with cancer. Cancer Control 4(5):419–428PubMed
14.
Zurück zum Zitat Riechelmann RP, Del Giglio A (2009) Drug interactions in oncology: how common are they? Ann Oncol 20:1907–1912PubMedCrossRef Riechelmann RP, Del Giglio A (2009) Drug interactions in oncology: how common are they? Ann Oncol 20:1907–1912PubMedCrossRef
15.
Zurück zum Zitat Glare P, Virik K, Jones M et al (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327(7408):195–198PubMedCrossRef Glare P, Virik K, Jones M et al (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327(7408):195–198PubMedCrossRef
16.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655PubMedCrossRef
17.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
18.
Zurück zum Zitat Curtis EB, Walsh TD (1993) Prescribing practices of a palliative care service. J Pain Symptom Manage 8(5):312–316PubMedCrossRef Curtis EB, Walsh TD (1993) Prescribing practices of a palliative care service. J Pain Symptom Manage 8(5):312–316PubMedCrossRef
19.
Zurück zum Zitat Mercadante S, Fulfaro F, Casuccio A (2001) Pattern of drug use by advanced cancer patients followed at home. J Palliat Care 17(1):37–40PubMed Mercadante S, Fulfaro F, Casuccio A (2001) Pattern of drug use by advanced cancer patients followed at home. J Palliat Care 17(1):37–40PubMed
20.
Zurück zum Zitat Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100–107PubMedCrossRef Nauck F, Ostgathe C, Klaschik E et al (2004) Drugs in palliative care: results from a representative survey in Germany. Palliat Med 18(2):100–107PubMedCrossRef
21.
Zurück zum Zitat Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J. (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. The International Journal of Pharmacy Practice (September issue):71 Nicholson A, Andrew I, Etherington R, Gamlin R, Lovel T, Lloyd J. (2001) Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a palliative care unit. The International Journal of Pharmacy Practice (September issue):71
22.
Zurück zum Zitat Kite S, Wilkinson S (2002) Beyond futility: to what extent is the concept of futility useful in clinical decision-making about CPR? Lancet Oncol 3(10):638–642PubMedCrossRef Kite S, Wilkinson S (2002) Beyond futility: to what extent is the concept of futility useful in clinical decision-making about CPR? Lancet Oncol 3(10):638–642PubMedCrossRef
23.
Zurück zum Zitat Vollrath AM, Sinclair C, Hallenbeck J (2005) Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 8(4):876–881PubMedCrossRef Vollrath AM, Sinclair C, Hallenbeck J (2005) Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliat Med 8(4):876–881PubMedCrossRef
24.
Zurück zum Zitat Samano ES, Ribeiro LM, Campos AS et al (2005) Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care (Engl) 14(2):143–148CrossRef Samano ES, Ribeiro LM, Campos AS et al (2005) Use of complementary and alternative medicine by Brazilian oncologists. Eur J Cancer Care (Engl) 14(2):143–148CrossRef
25.
Zurück zum Zitat Basu TK (1985) Drug–vitamin interaction. Int J Vitam Nutr Res Suppl 27:247–258PubMed Basu TK (1985) Drug–vitamin interaction. Int J Vitam Nutr Res Suppl 27:247–258PubMed
Metadaten
Titel
Use of unnecessary medications by patients with advanced cancer: cross-sectional survey
verfasst von
Angelo Fede
Michele Miranda
Daniella Antonangelo
Ligia Trevizan
Henrique Schaffhausser
Bruno Hamermesz
Camile Zimmermann
Auro Del Giglio
Rachel P. Riechelmann
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0947-1

Weitere Artikel der Ausgabe 9/2011

Supportive Care in Cancer 9/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.